TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33600729

Group type: EXPERIMENTAL
Intervention: Short-acting bronchodilators
Number of subjects: 579

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroid (ICS) therapy
Number of subjects: 579

Group type: COMPARATOR
Intervention: Severe exacerbation
Number of subjects: 579
Study: 32959409

Group type: EXPERIMENTAL
Intervention: Platelet transfusions with storage age of 1 to 7 days (majority 4 or 5 days)
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Platelet transfusions with fresher storage age
Number of subjects: 497
Study: 35180966

Group type: EXPERIMENTAL
Intervention: Plyometric exercise
Number of subjects: 10
Study: 34891528

Group type: EXPERIMENTAL
Intervention: Error-Augmented Visual Feedback (EA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard visual feedback (no EA)
Number of subjects: 0
Study: 36127418

Group type: EXPERIMENTAL
Intervention: Prolonged cycling at 90% of the estimated power output at first ventilatory threshold (VT1) for two hours
Number of subjects: 14
Study: 33561426

Group type: EXPERIMENTAL
Intervention: Oral dexamethasone 4 mg administered preemptively
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control side (no intervention)
Number of subjects: 22
Study: 32758281

Group type: EXPERIMENTAL
Intervention: Nurse-led health coaching intervention
Number of subjects: 0
Study: 34786952

Group type: EXPERIMENTAL
Intervention: Pulsed radiofrequency treatment (PRF) with pregabalin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Pregabalin alone
Number of subjects: 40
Study: 33198711

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist Control
Number of subjects: 0
Study: 34758073

Group type: EXPERIMENTAL
Intervention: 100 mg daily aspirin
Number of subjects: 19114

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19114
Study: 32487077

Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (tDCS) over the leg area of the primary motor cortex (M1) for 20 minutes
Number of subjects: 46

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 46
Study: 35896392

Group type: EXPERIMENTAL
Intervention: Sacrospinous ligament fixation (SSF)
Number of subjects: 81
Study: 32677716

Group type: EXPERIMENTAL
Intervention: Prophylactic argon plasma coagulation (APC)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Non-APC (control group)
Number of subjects: 54
Study: 32455135

Group type: EXPERIMENTAL
Intervention: Moderate or high levels of strength training
Number of subjects: 6561

Group type: COMPARATOR
Intervention: No strength training
Number of subjects: 6561
Study: 35227647

Group type: EXPERIMENTAL
Intervention: Inhaled AZD5634 (600 µg)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Inhaled AZD5634 (up to 1700 µg)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Inhaled AZD5634
Number of subjects: 64
Study: 34261371

Group type: EXPERIMENTAL
Intervention: Flurbiprofen 8.75 mg lozenges
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo lozenges
Number of subjects: 24
Study: 35730885

Group type: EXPERIMENTAL
Intervention: Carnoy's solution (CS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 10% neutral buffered formalin (NBF)
Number of subjects: 60
Study: 34580379

Group type: COMPARATOR
Intervention: I1: 100‐90% (control)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: I2: 80‐70%
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: I3: 60‐50%
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: I4: 30‐40%
Number of subjects: 3
Study: 35610627

Group type: EXPERIMENTAL
Intervention: Total Worker Health (TWH) leadership development program
Number of subjects: 250

Group type: COMPARATOR
Intervention: Control group (waitlisted)
Number of subjects: 250
Study: 33795257

Group type: EXPERIMENTAL
Intervention: Eribulin
Number of subjects: 77

Group type: COMPARATOR
Intervention: Dacarbazine
Number of subjects: 77
Study: 34399547

Group type: EXPERIMENTAL
Intervention: L-cysteine hydrochloride; concentration 4.23 mM at pH 8.71
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glutathione (GSH); concentration 3.78 mM at pH 8.51
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no added thiols); pH 8.9-9.3
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (0.82 mM thiols); pH 10.41
Number of subjects: 0
Study: 35686393

Group type: EXPERIMENTAL
Intervention: Technology-enhanced physical activity intervention (bi-weekly education sessions for 4 weeks, monthly small group walks for 8 weeks, weekly reminder text messages)
Number of subjects: 43
Study: 32921337

Group type: EXPERIMENTAL
Intervention: Lurasidone (40‐160 mg/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Quetiapine XR
Number of subjects: 0

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lurasidone (after switching from olanzapine or risperidone)
Number of subjects: 0
Study: 36261491

Group type: EXPERIMENTAL
Intervention: Gel group (poloxamer 407‐based 0.75% ropivacaine, 22.5 mg)
Number of subjects: 61

Group type: COMPARATOR
Intervention: On-Q group (0.2% ropivacaine, 4 mg/hour for two days)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Gel group
Number of subjects: 61

Group type: COMPARATOR
Intervention: On-Q group
Number of subjects: 61
Study: 34193128

Group type: EXPERIMENTAL
Intervention: Training on palliative care competencies and communication skills addressing end‐of‐life issues
Number of subjects: 8
Study: 32144166

Group type: EXPERIMENTAL
Intervention: Dalcetrapib 600 mg daily
Number of subjects: 15671

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15671
Study: 35927674

Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of 10^7 umbilical cord-derived Wharton's jelly mesenchymal stem cells (WJ-MSCs)
Number of subjects: 390

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 390
Study: 33326348

Group type: EXPERIMENTAL
Intervention: Family Support Tool
Number of subjects: 52

Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 52
Study: 33387811

Group type: EXPERIMENTAL
Intervention: Online decision aid
Number of subjects: 250
Study: 35582785

Group type: EXPERIMENTAL
Intervention: Dextromethorphan-bupropion (45 mg/105 mg tablet)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Bupropion (105 mg tablet)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Dextromethorphan-bupropion
Number of subjects: 80

Group type: COMPARATOR
Intervention: Bupropion
Number of subjects: 80
Study: 33546656

Group type: EXPERIMENTAL
Intervention: Stratified Blended Approach
Number of subjects: 238

Group type: COMPARATOR
Intervention: Usual physiotherapy
Number of subjects: 238
Study: 33864432

Group type: EXPERIMENTAL
Intervention: Lactobacillus casei (1 × 10^10 CFU/day)
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Lactobacillus casei (2 × 10^10 CFU/day)
Number of subjects: 429

Group type: COMPARATOR
Intervention: Standard tuberculosis therapy alone
Number of subjects: 429
Study: 34049428

Group type: EXPERIMENTAL
Intervention: Integrated neuromuscular inhibition technique (INIT)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Positional release technique (PRT)
Number of subjects: 48
Study: 34695552

Group type: EXPERIMENTAL
Intervention: Transfemoral carotid artery stenting (CAS)
Number of subjects: 2544

Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 2544

Group type: EXPERIMENTAL
Intervention: CAS
Number of subjects: 2544

Group type: COMPARATOR
Intervention: CEA
Number of subjects: 2544
Study: 32988969

Group type: EXPERIMENTAL
Intervention: Exemestane 50 mg with enzalutamide 160 mg daily
Number of subjects: 247

Group type: COMPARATOR
Intervention: Exemestane 25 mg with placebo
Number of subjects: 247
Study: 36397443

Group type: EXPERIMENTAL
Intervention: Family-involved smart medication management system
Number of subjects: 82

Group type: COMPARATOR
Intervention: Routine medication management model
Number of subjects: 82
Study: 33297821

Group type: EXPERIMENTAL
Intervention: Direct TAVR group (no prior balloon aortic valvuloplasty)
Number of subjects: 211

Group type: COMPARATOR
Intervention: BAV group (prior balloon aortic valvuloplasty)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 211
Study: 35568805

Group type: EXPERIMENTAL
Intervention: Tablet-based physiotherapy training programme at home for nine months
Number of subjects: 230

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 230
Study: 34787449

Group type: EXPERIMENTAL
Intervention: MenABCWY vaccine
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: 4CMenB+ACWY/S group
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: 4CMenB+ACWY/D group
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: 4CMenB group
Number of subjects: 500
Study: 33983107

Group type: EXPERIMENTAL
Intervention: Wheat germ (20 g)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 34337526

Group type: EXPERIMENTAL
Intervention: 40 mg high-dose estetrol (HDE4) for 24 weeks
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 36440678

Group type: EXPERIMENTAL
Intervention: Online counseling education program (7-hours self-directed learning; 3-hour online workshop)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 49
Study: 33206257

Group type: COMPARATOR
Intervention: Prophylactic antibiotics (PA)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Immunoglobulin replacement therapy (IRT)
Number of subjects: 64
Study: 32308117

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Positive social interaction (partner appraisal task)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 34259591

Group type: EXPERIMENTAL
Intervention: Artificially generated double inversion recovery images (aDIR)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Conventionally acquired double inversion recovery images (cDIR)
Number of subjects: 73
Study: 34261076

Group type: EXPERIMENTAL
Intervention: PRP subcutaneous injection
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 200
Study: 35894919

Group type: EXPERIMENTAL
Intervention: Supervised concurrent (aerobic + resistance) exercise program, 3 days/week
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Increasing cardiorespiratory fitness, muscle strength, and sleep duration
Number of subjects: 101
Study: 33428631

Group type: EXPERIMENTAL
Intervention: Over-the-counter (OTC) medications for CIC, including bisacodyl (33%) and polyethylene glycol (30%)
Number of subjects: 1423
Study: 35988193

Group type: EXPERIMENTAL
Intervention: LEEP under propofol intravenous anesthesia combined with nano-silver gel
Number of subjects: 100

Group type: COMPARATOR
Intervention: LEEP under intravenous anesthesia with fentanyl
Number of subjects: 100
Study: 34074227

Group type: EXPERIMENTAL
Intervention: 6 weeks of eccentric hamstring training at long muscle length
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (usual activities)
Number of subjects: 34
Study: 34928443

Group type: EXPERIMENTAL
Intervention: Higher average OA z-score
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Higher PC3
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Methylmalonate, citrate/isocitrate, ethylmalonate, lactate
Number of subjects: 281
Study: 36028847

Group type: EXPERIMENTAL
Intervention: True acupuncture
Number of subjects: 280

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 280
Study: 33819489

Group type: EXPERIMENTAL
Intervention: Star‐shape Kinesio taping (KT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Minimal Intervention (MI)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Sham Kinesio taping (KT)
Number of subjects: 120
Study: 35264362

Group type: COMPARATOR
Intervention: 0 mg iron supplementation (placebo)
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: 30 mg iron supplementation
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: 60 mg iron supplementation
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Iron supplementation on alternate days
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Iron supplementation daily for 56 days
Number of subjects: 1200
Study: 32301028

Group type: COMPARATOR
Intervention: Anodal tDCS (10-day intervention)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Anodal tDCS (10 days a month for 8 months)
Number of subjects: 44
Study: 32091670

Group type: EXPERIMENTAL
Intervention: Strength training (ST) twice a week for 10 weeks
Number of subjects: 34

Group type: COMPARATOR
Intervention: Non-exercising control group (CON)
Number of subjects: 34
Study: 35976462

Group type: EXPERIMENTAL
Intervention: Text reminder with specific scheduling options
Number of subjects: 1277

Group type: EXPERIMENTAL
Intervention: Text reminder with open-ended scheduling options
Number of subjects: 1277

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 1277

Group type: EXPERIMENTAL
Intervention: Text-based reminder and scheduling opportunity
Number of subjects: 1277
Study: 33449326

Group type: EXPERIMENTAL
Intervention: Lidocaine gel pre and post flexible cystoscopy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Lidocaine gel pre flexible cystoscopy only
Number of subjects: 50
Study: 34242472

Group type: EXPERIMENTAL
Intervention: Supratherapeutic venlafaxine 450 mg/d
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg (positive control)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 34715839

Group type: EXPERIMENTAL
Intervention: 6 mL 2%‐lidocaine intracervical block
Number of subjects: 100

Group type: COMPARATOR
Intervention: 550 mg naproxen
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Lidocaine intracervical block
Number of subjects: 100

Group type: COMPARATOR
Intervention: Naproxen
Number of subjects: 100
Study: 32421854

Group type: EXPERIMENTAL
Intervention: VT-1161 300 mg (2-week daily dose, followed by once-weekly for 10 or 22 weeks)
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: VT-1161 600 mg (2-week daily dose, followed by once-weekly for 10 or 22 weeks)
Number of subjects: 259

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 259
Study: 33408039

Group type: EXPERIMENTAL
Intervention: Cemented Oxford UKR
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Cementless Oxford UKR
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Cementless tibial component
Number of subjects: 39

Group type: COMPARATOR
Intervention: Cemented tibial component
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Cementless tibial components
Number of subjects: 39

Group type: COMPARATOR
Intervention: Cemented tibial components
Number of subjects: 39
Study: 33754923

Group type: EXPERIMENTAL
Intervention: Red spinach extract (RSE) 2g daily (180mg nitrate)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 16
Study: 33836216

Group type: EXPERIMENTAL
Intervention: 1/4 lower-energy options on fuller shelves
Number of subjects: 2479

Group type: EXPERIMENTAL
Intervention: 3/4 lower-energy options on fuller shelves
Number of subjects: 2479

Group type: EXPERIMENTAL
Intervention: 1/4 lower-energy options on emptier shelves
Number of subjects: 2479

Group type: EXPERIMENTAL
Intervention: 3/4 lower-energy options on emptier shelves
Number of subjects: 2479

Group type: EXPERIMENTAL
Intervention: 2/3 lower-energy snacks on fuller trays
Number of subjects: 2479

Group type: EXPERIMENTAL
Intervention: 1/3 lower-energy snacks on fuller trays
Number of subjects: 2479

Group type: EXPERIMENTAL
Intervention: 1/3 lower-energy snacks on emptier trays
Number of subjects: 2479

Group type: EXPERIMENTAL
Intervention: 2/3 lower-energy snacks on emptier trays
Number of subjects: 2479
Study: 33491787

Group type: EXPERIMENTAL
Intervention: Oral potassium and magnesium supplements administered pre-procedure based on pre-electrolyte levels.
Number of subjects: 136

Group type: COMPARATOR
Intervention: Historic cohort (2010-2013) without electrolyte intervention.
Number of subjects: 136
Study: 32269534

Group type: EXPERIMENTAL
Intervention: SCIT-VR therapy delivered through the virtual world platform Second Life©, 8 sessions over a 5-week intervention window.
Number of subjects: 15
Study: 33632476

Group type: EXPERIMENTAL
Intervention: Transcatheter mitral valve repair (TMVr) plus GDMT
Number of subjects: 614

Group type: COMPARATOR
Intervention: Guideline-directed medical therapy (GDMT) alone
Number of subjects: 614

Group type: COMPARATOR
Intervention: GDMT alone followed by TMVr (crossover group)
Number of subjects: 614
Study: 33115527

Group type: EXPERIMENTAL
Intervention: Optimized statistical process control (SPC) charts for SSI surveillance and feedback
Number of subjects: 105

Group type: COMPARATOR
Intervention: Traditional surveillance for SSIs
Number of subjects: 105
Study: 35183469

Group type: EXPERIMENTAL
Intervention: Intraoperative CPN
Number of subjects: 70

Group type: COMPARATOR
Intervention: CT-guided CPN
Number of subjects: 70
Study: 33413593

Group type: EXPERIMENTAL
Intervention: Goal-Directed Fluid Therapy (GDFT)
Number of subjects: 276

Group type: COMPARATOR
Intervention: Restrictive Fluid Therapy combined with Enhanced Recovery After Surgery (ERAS) protocol
Number of subjects: 276
Study: 33478409

Group type: EXPERIMENTAL
Intervention: Cancer Worry Scale (CWS)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Self-Management Skill Scale (SMSS)
Number of subjects: 50
Study: 35893335

Group type: EXPERIMENTAL
Intervention: Real-time feedback device
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control (no feedback)
Number of subjects: 72
Study: 32613871

Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 73

Group type: COMPARATOR
Intervention: Popular science program (Control)
Number of subjects: 73
Study: 32796546

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids, β-alanine, and carnosine intake from a diet with 55% carbohydrate, 30% fat, and 15% protein for 14 days followed by gravity-independent resistive exercise.
Number of subjects: 21
Study: 35653696

Group type: EXPERIMENTAL
Intervention: Improved cookstoves
Number of subjects: 4010

Group type: EXPERIMENTAL
Intervention: Improved cookstoves (subset analysis)
Number of subjects: 4010

Group type: COMPARATOR
Intervention: Control (open fires or highly polluting cookstoves)
Number of subjects: 4010
Study: 32077071

Group type: EXPERIMENTAL
Intervention: Integrated task set group (one task set)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Separate task set group (two task sets)
Number of subjects: 0
Study: 34542204

Group type: EXPERIMENTAL
Intervention: Spirulina-fortified dressing (2 g of spirulina platensis powder)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo dressing
Number of subjects: 48
Study: 35527689

Group type: EXPERIMENTAL
Intervention: Battlefield Acupuncture (BFA)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Sham Acupuncture
Number of subjects: 72
Study: 33293319

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI) including total dietary replacement phase using meal replacement products, followed by staged food reintroduction and physical activity support.
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Usual medical care
Number of subjects: 147
Study: 35830312

Group type: EXPERIMENTAL
Intervention: Immediate postextraction implants with grafting the bone‐to‐implant gap (Group A)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delayed implants inserted after alveolar ridge preservation (Group B)
Number of subjects: 0
Study: 33624548

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 30
Study: 32799804

Group type: EXPERIMENTAL
Intervention: Bothersome ED
Number of subjects: 2888
Study: 35712259

Group type: EXPERIMENTAL
Intervention: Insulin pump with independent intermittent scanning continuous glucose monitoring (iscCGM, Freestyle libre ®)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Sensor augmented pump (SAP) with predictive low glucose suspend (SmartGuard®)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Overall treatment preference after one year
Number of subjects: 31
Study: 35108185

Group type: EXPERIMENTAL
Intervention: One-stage treatment protocol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Two-stage treatment protocol
Number of subjects: 0
Study: 35943380

Group type: EXPERIMENTAL
Intervention: iTRAC intervention (4-module digital intervention)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 85
Study: 33607792

Group type: EXPERIMENTAL
Intervention: Periarticular injection (PAI) of multimodal drugs
Number of subjects: 56

Group type: COMPARATOR
Intervention: Saline injection (Control)
Number of subjects: 56
Study: 32251249

Group type: EXPERIMENTAL
Intervention: Volar plate with addition of a dorsal‐ulnar pin plate
Number of subjects: 18

Group type: COMPARATOR
Intervention: Volar plate only
Number of subjects: 18
Study: 35938544

Group type: EXPERIMENTAL
Intervention: Afatinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 0
Study: 34160391

Group type: EXPERIMENTAL
Intervention: Bismuth breast shield after the scout view
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Bismuth breast shield before the scout view
Number of subjects: 3

Group type: COMPARATOR
Intervention: No shielding
Number of subjects: 3
Study: 32745667

Group type: EXPERIMENTAL
Intervention: Increased planned radiotherapy dose (>55 Gy) in a small rectal volume adjacent to the clinical target volume.
Number of subjects: 1286

Group type: EXPERIMENTAL
Intervention: Increased low-intermediate planned radiotherapy dose (∼25 Gy) at the posterior beam region, including the posterior rectum and perirectal fat space (PRFS).
Number of subjects: 1286
Study: 35765223

Group type: EXPERIMENTAL
Intervention: Acupoint injection of mecobalamin at Zusanli (S36)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intramuscular injection of mecobalamin
Number of subjects: 40